Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.18NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
B.1.36.18SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.177.32NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.177.32SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.1.59NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
B.1.1.59SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.177.67NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.177.67SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
DN.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DN.1.1.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.626NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.626SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.629NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.629SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
GA.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GA.9SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
AY.61 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.61 (Delta)SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.2.75.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.75.6SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
GC.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GC.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-1311.99Japan
BQ.1.1.16NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.16SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.1.524NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.524SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.5.2.38NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.5.2.38SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.1.15.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1.15.3SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.1.15NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.15SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
AY.59 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.59 (Delta)SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
XBRNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBRSWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
DJ.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DJ.1.1.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
CH.1.1.21NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26074.3US
CH.1.1.21SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
AZ.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AZ.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.1.193NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
B.1.1.193SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BL.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BL.4SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
FP.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FP.3SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
DA.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DA.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used